Pretty impressive result given the current economic environment.
Strong cash position with no debt and strong growth across key metrics - imo this should be worth double the current market cap
- Forums
- ASX - By Stock
- Ann: FY23 Preliminary Results Update
Pretty impressive result given the current economic...
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NXL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$3.39 |
Change
-0.115(3.29%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
$3.47 | $3.52 | $3.37 | $2.206M | 641.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
38 | 9507 | $3.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.39 | 6995 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
35 | 9048 | 3.380 |
32 | 26532 | 3.370 |
24 | 13730 | 3.360 |
7 | 24822 | 3.350 |
6 | 5229 | 3.340 |
Price($) | Vol. | No. |
---|---|---|
3.390 | 7957 | 16 |
3.400 | 6158 | 8 |
3.410 | 19266 | 11 |
3.420 | 21240 | 8 |
3.430 | 5560 | 3 |
Last trade - 15.16pm 15/07/2024 (20 minute delay) ? |
Featured News
NXL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online